Insider Trading activities of Agile Therapeutics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agile Therapeutics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Agile Therapeutics Inc since year 2005. Table 2 shows the detailed insider transactions of Agile Therapeutics Inc since 2005. The reporting company's ticker symbol is AGRX. The reporting company's CIK number is 1261249.
The total value of stock buying since 2005 is $51,095,564.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $162,650.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Agile Therapeutics Inc (AGRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-08 17,250 $57,687 0 $0 0 $0
2017-06 0 $0 0 $0 7,000 $26,250
2017-05 63,333 $231,365 0 $0 0 $0
2017-04 0 $0 0 $0 30,000 $52,800
2017-02 0 $0 0 $0 16,667 $0
2016-02 0 $0 0 $0 16,666 $0
2016-01 393,700 $2,499,995 0 $0 0 $0
2015-06 2,500 $21,825 0 $0 0 $0
2015-03 0 $0 0 $0 17,500 $30,800
2015-01 1,623,932 $9,500,002 0 $0 0 $0
2014-12 0 $0 0 $0 30,000 $52,800
2014-05 6,464,115 $38,784,690 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Agile Therapeutics Inc insiders (AGRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-08-25 Selman Renee (Chief Commercial Officer) Buy 7,250 3.35 24,287
2017-08-25 Altomari Alfred (Chairman & Chief Executive Officer) Buy 10,000 3.34 33,400
2017-06-12 Shetty Ajit (Director) Option Ex 7,000 3.75 26,250
2017-05-11 Selman Renee (Chief Commercial Officer) Buy 53,333 3.68 196,265
2017-05-11 Altomari Alfred (Chairman and Chief Executive O) Buy 10,000 3.51 35,100
2017-04-11 Altomari Alfred (Chairman & Chief Exec Officer) Option Ex 30,000 1.76 52,800
2017-02-08 Altomari Alfred (Chief Executive Officer) Option Ex 16,667 .00 0
2016-02-08 Altomari Alfred (Chief Executive Officer) Option Ex 16,666 .00 0
2016-01-27 Proquest Associates Iv Llc (10% Owner) Buy 393,700 6.35 2,499,995
2015-06-02 Altomari Alfred (Chief Executive Officer) Buy 2,500 8.73 21,825
2015-03-11 Altomari Alfred (Chief Executive Officer) Option Ex 17,500 1.76 30,800
2015-01-23 Proquest Associates Iv Llc (10% Owner) Buy 811,966 5.85 4,750,001
2015-01-23 Schiff Andrew N Buy 811,966 5.85 4,750,001
2014-12-18 Altomari Alfred (Chief Executive Officer) Option Ex 30,000 1.76 52,800
2014-05-29 Care Capital Offshore Investments Iii Lp (10% Owner) Buy 500,000 6.00 3,000,000
2014-05-29 Proquest Associates Iv Llc (10% Owner) Buy 1,120,833 6.00 6,724,998
2014-05-29 Investor Ab Buy 2,509,949 6.00 15,059,694
2014-05-23 Schiff Andrew N Buy 1,333,333 6.00 7,999,998
2014-05-22 Investor Ab Buy 1,000,000 6.00 6,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of AGRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Agile Therapeutics Inc (symbol AGRX, CIK number 1261249) see the Securities and Exchange Commission (SEC) website.